Product Information
TOLVAPTAN 30 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $72.5518 per EA under NDC 67877063633. Its NADAC has been published 74 times since Jul 17, 2024.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877063633
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
12/18/2024
Active Ingredients
TOLVAPTANApproval Type
Generic (ANDA)
FDA Application
ANDA211891On Market Since
5/21/2020
Pharmacological Classes
Price Statistics
The NADAC for TOLVAPTAN 30 MG TABLET has been published 74 times since Jul 17, 2024, and over the history we have for it it has risen 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $72.5518 per EA |
|---|---|
| All-time high | $72.5518 (Dec 10, 2025) |
| All-time low | $58.3386 (Jul 17, 2024) |
| 52-week high | $72.5518 |
| 52-week low | $72.5518 |
| Median price | $72.5518 |
| Average price | $69.8628 |
| Largest weekly change | +24.4% (Oct 23, 2024) |
| Weeks tracked | 74 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TOLVAPTAN 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TOLVAPTAN 30 MG TABLET, manufactured by Ascend Laboratories, LLC, is $72.5518 per EA (NDC 67877063633), effective Dec 10, 2025.
How has the price of TOLVAPTAN 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for TOLVAPTAN 30 MG TABLET has risen 24.4%. It has been tracked across 74 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for TOLVAPTAN 30 MG TABLET?
Since Jul 17, 2024, the NADAC for TOLVAPTAN 30 MG TABLET has ranged from a low of $58.3386 (Jul 17, 2024) to a high of $72.5518 (Dec 10, 2025), with a median of $72.5518 per EA.
Are there cheaper alternatives to TOLVAPTAN 30 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TOLVAPTAN 30 MG TABLET, but none are currently priced below it.
Who manufactures TOLVAPTAN 30 MG TABLET?
TOLVAPTAN 30 MG TABLET (NDC 67877063633) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification